Who should be treated for nontuberculous mycobacterial pulmonary disease?

被引：0
作者：
Ito, Yutaka [1 ]
机构：
[1] Nagoya City Univ, Dept Resp Med Allergy & Clin Immunol, Grad Sch Med Sci, 1 Kawasumi,Mizuho Cho,Mizuho Ku, Nagoya, Aichi 4678601, Japan
来源：
RESPIRATORY INVESTIGATION | 2023年 / 61卷 / 04期
关键词：
Nontuberculous mycobacteria; Guideline; Treatment; Sputum conversion; Patient-reported outcome; INFECTION;
D O I：
10.1016/j.resinv.2023.03.002
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：387 / 388
页数：2
相关论文
共 19 条
  • [1] PULMONARY INFECTION WITH NONTUBERCULOUS MYCOBACTERIA
    CONTRERAS, MA
    CHEUNG, OT
    SANDERS, DE
    GOLDSTEIN, RS
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (01): : 149 - 152
  • [2] Daley CL., 2020, CLIN INFECT DIS, V56, DOI DOI 10.1183/13993003.00535-2020
  • [3] Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
    Fujita, Kohei
    Ito, Yutaka
    Hirai, Toyohiro
    Kubo, Takeshi
    Togashi, Kaori
    Ichiyama, Satoshi
    Mishima, Michiaki
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2013, 1 (01):
  • [4] Fujita Kohei, 2014, Ann Am Thorac Soc, V11, P45, DOI 10.1513/AnnalsATS.201309-297OC
  • [5] Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
    Hayashi, Makoto
    Takayanagi, Noboru
    Kanauchi, Tetsu
    Miyahara, Yousuke
    Yanagisawa, Tsutomu
    Sugita, Yutaka
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (05) : 575 - 583
  • [6] Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course
    Hwang, Ji An
    Kim, Sunyoung
    Jo, Kyung-Wook
    Shim, Tae Sun
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [7] Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease
    Ito, Y.
    Hirai, T.
    Maekawa, K.
    Fujita, K.
    Imai, S.
    Tatsumi, S.
    Handa, T.
    Matsumoto, H.
    Muro, S.
    Niimi, A.
    Mishima, M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (03) : 408 - 414
  • [8] The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease
    Ito, Yutaka
    Hirai, Toyohiro
    Fujita, Kohei
    Kubo, Takeshi
    Maekawa, Koichi
    Ichiyama, Satoshi
    Togashi, Kaori
    Mishima, Michiaki
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [9] Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study
    Jhun, Byung Woo
    Moon, Seong Mi
    Jeon, Kyeongman
    Kwon, O. Jung
    Yoo, Heejin
    Carriere, Keumhee C.
    Huh, Hee Jae
    Lee, Nam Yong
    Shin, Sung Jae
    Daley, Charles L.
    Koh, Won-Jung
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (01)
  • [10] Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease
    Kim, Joong-Yub
    Kim, Na Young
    Jung, Hee-Won
    Yim, Jae-Joon
    Kwak, Nakwon
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
12